Tekla Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Other funds holding ALNY
Tekla Capital Management's ALNY Position: Q2 2023 in Review
Tekla Capital Management held its Alnylam Pharmaceuticals (ALNY) position steady in Q2 2023 at 143,214 shares worth $27.2M. The position accounts for 1.06% of the portfolio, ranked #25.
Tekla Capital Management first reported a position in ALNY in Q3 2013 and has held it in 40 quarters since. The position peaked at $35.8M in Q3 2021. 477 funds tracked by Wall St. Rank hold ALNY as of Q2 2023.
- Tekla Capital Management held 143,214 shares of Alnylam Pharmaceuticals worth $27.2M as of Q2 2023.
- Tekla Capital Management left its Alnylam Pharmaceuticals share count unchanged in Q2 2023.
- Alnylam Pharmaceuticals made up 1.06% of Tekla Capital Management's portfolio in Q2 2023, its #25 holding.
- Tekla Capital Management first reported a position in Alnylam Pharmaceuticals in Q3 2013 and has held it in 40 quarters since.
- Tekla Capital Management's Alnylam Pharmaceuticals position peaked at $35.8M in Q3 2021.
- 477 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2023.
Based on Tekla Capital Management's 13F filing for Q2 2023, filed 10 Aug 2023.